CCND1 and neuroblastoma: Our results showed that the inhibitors alone or in combination with chemotherapy significantly downregulated the expression of MYCN, Cyclin D1 and Bcl-2 molecules and upregulated the expression of tumor-suppressor proteins p21 and p53 in all three neuroblastoma cell lines.